Loading…

A high prevalence of organ-specific autoimmunity in patients with bipolar disorder

In a previous study, we reported an increased prevalence of thyroperoxidase antibodies (TPOA) in patients with bipolar disorder. Here we report the prevalence of other organ-specific autoantibodies: H/K adenosine triphosphatase (ATPA), glutamic acid decarboxylase-65 (GAD65A), and GAD-67 (GAD67A). AT...

Full description

Saved in:
Bibliographic Details
Published in:Biological psychiatry (1969) 2004-10, Vol.56 (7), p.476-482
Main Authors: Padmos, Roos C., Bekris, Lynn, Knijff, Esther M., Tiemeier, Henning, Kupka, Ralph W., Cohen, Dan, Nolen, Willem A., Lernmark, Åke, Drexhage, Hemmo A.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In a previous study, we reported an increased prevalence of thyroperoxidase antibodies (TPOA) in patients with bipolar disorder. Here we report the prevalence of other organ-specific autoantibodies: H/K adenosine triphosphatase (ATPA), glutamic acid decarboxylase-65 (GAD65A), and GAD-67 (GAD67A). ATPA, GAD65A, and GAD67A were determined (via a commercially available enzyme linked immunosorbent assay for ATPA, and a standardized radio immunoassays for GAD65A and GAD67A)in the sera of 239 patients with DSM-IV bipolar disorder, in 74 patients with DSM-IV schizophrenia, and in 220 healthy control subjects. The positivity prevalences for ATPA and GAD65A (but not GAD67A) were elevated in bipolar patients compared with those in healthy control subjects (11.7 vs. 6.1% and 11.3 vs. 2.6% respectively; p
ISSN:0006-3223
1873-2402
DOI:10.1016/j.biopsych.2004.07.003